# Persisting Effects of Psilocybin

> **NCT02971605** · PHASE1,PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 13 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT02971605
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2018-08-21
- **Final completion:** 2018-08-21
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2019-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971605, "Persisting Effects of Psilocybin". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02971605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*